Professor Lee Jin-hwa of the Dongtan Sacred Heart Hospital of Hallym University won the International Conference on Cardiovascular Intervention and the Excellence Award
Oct 28, 2024
Lee Jin-hwa, a professor of circulatory technology at Hallym University Dongtan Sacred Heart Hospital, won the Excellence Award at the International Intervention Society, 『Encore Seoul 2024" (Endovascular & Coronary Revascularization in Seoul 2024), held at Grand Intercontinental Seoul Parnas on the 11th.
Professor Jinhwa Lee was honored with the presentation of 'Effectiveness and Stability of a New Parklitaxel Coated Balloon with Shellac and Vitamin E excipients: a prospective, multicenter, single-group study of patients with novel coronary artery lesions'.
Drug-coated balloons have recently attracted attention as a novel treatment in the treatment of coronary stenosis, in which the coronary arteries supplying blood to the heart are narrowed or blocked. The treatment covers the drug-coated stent with a balloon and then approaches the area where the coronary artery is constricted. After that, the balloon is inflated, a stent is inserted, and the drug is released to treat blood vessels.
In this study, 20 patients with coronary stenosis underwent coronary artery surgery with a new paclitaxel-coated balloon (hereinafter GENOSS DCB)' with shellac and vitamin E excipients developed by Korean researchers. The main evaluation index was late lumen loss after 6 months.
As a result of the study, the procedure was successful in all patients and the loss of the lumen of blood vessels was observed at -0.17±0.3㎜ at 6 months of follow-up, indicating a significant improvement in blood vessel condition. In addition, there was no restenosis of blood vessels, and vascular patency was maintained. In addition, it showed a stable treatment effect for 6 months without the occurrence of major cardiovascular diseases such as myocardial infarction.
Professor Lee Jin-hwa "This study confirms that GENOSS DCB developed in Korea can be a safe and effective alternative to coronary artery disease"We will continue our research to provide better treatments for patients in the future."."
Professor Jinhwa Lee was honored with the presentation of 'Effectiveness and Stability of a New Parklitaxel Coated Balloon with Shellac and Vitamin E excipients: a prospective, multicenter, single-group study of patients with novel coronary artery lesions'.
Drug-coated balloons have recently attracted attention as a novel treatment in the treatment of coronary stenosis, in which the coronary arteries supplying blood to the heart are narrowed or blocked. The treatment covers the drug-coated stent with a balloon and then approaches the area where the coronary artery is constricted. After that, the balloon is inflated, a stent is inserted, and the drug is released to treat blood vessels.
In this study, 20 patients with coronary stenosis underwent coronary artery surgery with a new paclitaxel-coated balloon (hereinafter GENOSS DCB)' with shellac and vitamin E excipients developed by Korean researchers. The main evaluation index was late lumen loss after 6 months.
As a result of the study, the procedure was successful in all patients and the loss of the lumen of blood vessels was observed at -0.17±0.3㎜ at 6 months of follow-up, indicating a significant improvement in blood vessel condition. In addition, there was no restenosis of blood vessels, and vascular patency was maintained. In addition, it showed a stable treatment effect for 6 months without the occurrence of major cardiovascular diseases such as myocardial infarction.
Professor Lee Jin-hwa "This study confirms that GENOSS DCB developed in Korea can be a safe and effective alternative to coronary artery disease"We will continue our research to provide better treatments for patients in the future."."
|
bellho@sportschosun.com
